T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
ScottsMiracle-Gro
SMG
$3.59B
| $76.1M | 0.02% |
1,087,912
-354,570
| -25% | -$24.6M |
|
652
Simpson Manufacturing
SSD
$8B
| $75.7M | 0.02% |
1,894,900
+57,920
| +3% | +$2.23M |
|
653
Watsco Inc
WSO
$12.9B
| $74.9M | 0.02% |
532,085
+521,632
| +4,990% | +$70M |
|
654
Brunswick
BC
$5.29B
| $74.4M | 0.02% |
1,642,638
-141,120
| -8% | -$6.69M |
|
655
Columbia Banking Systems
COLB
$9.18B
| $74M | 0.02% |
2,636,499
+284,910
| +12% | +$8.36M |
|
|
AGN.PRA
656
DELISTED
Allergan plc
AGN.PRA
| $74M | 0.02% |
89,636
-148,820
| -62% | -$124M |
|
|
CBF
657
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $73.8M | 0.02% |
2,563,730
+53,060
| +2% | +$1.61M |
|
658
Gentherm
THRM
$1.32B
| $73.5M | 0.02% |
2,144,709
-4,690
| -0.2% | -$178K |
|
|
TCO
659
DELISTED
Taubman Centers Inc.
TCO
| $73.2M | 0.02% |
986,981
+216,027
| +28% | +$15.2M |
|
660
RLI Corp
RLI
$5.87B
| $72.2M | 0.02% |
2,098,520
-23,980
| -1% | -$781K |
|
661
Exponent
EXPO
$3.24B
| $71.4M | 0.02% |
2,445,576
+84,040
| +4% | +$2.19M |
|
662
McGrath RentCorp
MGRC
$2.94B
| $71.3M | 0.02% |
2,332,040
-4,700
| -0.2% | -$127K |
|
663
Hexcel
HXL
$7.74B
| $71.3M | 0.02% |
1,712,859
+8,189
| +0.5% | +$358K |
|
|
DENN
664
DELISTED
Denny's
DENN
| $71.3M | 0.02% |
6,644,959
+27,670
| +0.4% | +$292K |
|
665
Murphy USA
MUSA
$10.4B
| $70.6M | 0.02% |
951,530
+57,992
| +6% | +$3.78M |
|
666
J&J Snack Foods
JJSF
$1.7B
| $69.9M | 0.01% |
586,278
+3,090
| +0.5% | +$327K |
|
667
Red Robin
RRGB
$183M
| $69.6M | 0.01% |
1,467,383
+208,780
| +17% | +$12.1M |
|
668
Cencora
COR
$59.2B
| $69.4M | 0.01% |
875,369
-70,771
| -7% | -$5.68M |
|
669
Credicorp
BAP
$29.8B
| $69.4M | 0.01% |
449,699
+54,240
| +14% | +$7.77M |
|
670
Diodes
DIOD
$4.48B
| $69.3M | 0.01% |
3,688,942
+462,230
| +14% | +$8.75M |
|
671
Steven Madden
SHOO
$3.46B
| $69.2M | 0.01% |
3,037,356
-504,867
| -14% | -$11.6M |
|
672
UFP Industries
UFPI
$5.03B
| $68.4M | 0.01% |
2,213,670
-31,230
| -1% | -$879K |
|
|
SPLS
673
DELISTED
Staples Inc
SPLS
| $68.3M | 0.01% |
7,928,768
-1,992,760
| -20% | -$19M |
|
|
TUMI
674
DELISTED
TUMI HLDGS INC COM
TUMI
| $68.1M | 0.01% |
2,547,795
-26,259
| -1% | -$702K |
|
|
RSE
675
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $67.9M | 0.01% |
3,722,060
-26,600
| -0.7% | -$487K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.